Clinical Trial Update: A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors [Phase 2]

View source ↗

Summary

A Phase 2 study of SerpinPC in participants with Hemophilia B with inhibitors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Hemophilia with Inhibitors

Drugs mentioned

• SerpinPC

Snippet

Sponsor: ApcinteX Ltd | Conditions: Hemophilia B with Inhibitor, Hemophilia B | Phase 2 | Status: TERMINATED